The global industry was valued at US$ 3.8 Bn in 2022 and is estimated to grow at a CAGR of 6.0% from 2023 to 2031, reaching US$ 6.4 Bn by the end of 2031. The insomnia market is witnessing significant growth as sleep disorders become increasingly prevalent across the globe due to rising stress levels, changing lifestyles, mental health concerns, and growing awareness regarding the importance of sleep health. Insomnia, one of the most common sleep disorders, affects millions of individuals worldwide and has become a major public health concern due to its impact on physical health, cognitive performance, and emotional well-being. Increasing diagnosis rates and advancements in therapeutic solutions are expected to continue driving market expansion over the coming years.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20246
Market Overview
The insomnia market has evolved rapidly with growing recognition of sleep disorders as a serious medical condition rather than a lifestyle inconvenience. Factors such as long working hours, digital screen exposure, anxiety, depression, and chronic illnesses are contributing significantly to the rising prevalence of insomnia among both adults and elderly populations. Healthcare providers and pharmaceutical companies are increasingly focusing on innovative treatment approaches, including prescription medications, cognitive behavioral therapy for insomnia (CBT-I), and digital therapeutics. Additionally, growing awareness campaigns regarding sleep hygiene and mental wellness are encouraging more patients to seek diagnosis and treatment, thereby boosting market demand globally.
Market Size and Growth
Valued at US$ 3.8 Bn in 2022, the insomnia market is projected to reach US$ 6.4 Bn by the end of 2031, expanding at a CAGR of 6.0% during the forecast period. This steady growth is being driven by the increasing prevalence of chronic sleep disorders, growing mental health challenges, and the rising adoption of advanced pharmaceutical therapies. The demand for effective insomnia treatments has surged as healthcare systems and employers recognize the long-term health and productivity impacts associated with poor sleep quality. Furthermore, technological advancements in sleep monitoring devices and telemedicine platforms are making diagnosis and treatment more accessible, particularly in urban populations and developed healthcare markets.
Market Segmentation
The insomnia market can be segmented based on treatment type, indication, and distribution channel. By treatment type, the market includes pharmacological therapies, behavioral therapies, and alternative treatments, with pharmaceutical drugs currently accounting for a substantial market share due to widespread usage and rapid symptom management. In terms of indication, the market covers acute insomnia, chronic insomnia, and comorbid insomnia associated with psychiatric or medical conditions. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with online distribution channels witnessing rapid growth due to increasing digital healthcare adoption and consumer convenience. Rising interest in personalized treatment plans is also shaping future segmentation trends.
Regional Analysis
Regionally, North America dominates the insomnia market owing to high awareness levels, advanced healthcare infrastructure, strong pharmaceutical presence, and increasing stress-related disorders among the population. Europe represents another significant market driven by rising healthcare spending and increasing focus on mental wellness and sleep health. Asia-Pacific is expected to witness the fastest growth during the forecast period due to rapid urbanization, changing lifestyles, increasing work-related stress, and expanding healthcare access in countries such as China, India, and Japan. Meanwhile, Latin America and the Middle East & Africa are emerging markets where improving healthcare infrastructure and rising awareness regarding sleep disorders are creating new growth opportunities.
Competitive Landscape
The insomnia market is highly competitive, with pharmaceutical companies focusing on research and development, product innovation, strategic collaborations, and regulatory approvals to strengthen their market positions. Key companies operating in this market include Paratek Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries Limited, Vanda Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Sanofi S.A, Merck & Co., Inc., and Viatris Inc. These companies are actively investing in the development of safer and more effective insomnia therapies with fewer side effects and improved patient outcomes. Strategic acquisitions and partnerships are also helping companies expand their product portfolios and global reach.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: [phone]
USA – Canada Toll Free: 866-552-3453